Search Results - "Bloss, J. D."

Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement by Goldstein, R. B, Bree, R. L, Benson, C. B, Benacerraf, B. R, Bloss, J. D, Carlos, R, Fleischer, A. C, Goldstein, S. R, Hunt, R. B, Kurman, R. J, Kurtz, A. B, Laing, F. C, Parsons, A. K, Smith-Bindman, R, Walker, J

“…A panel of 14 physicians practicing medicine in the United States with expertise in radiology, obstetrics and gynecology, gynecologic oncology, hysteroscopy,…”
Get full text

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary by Bloss, J D, Liao, S Y, Buller, R E, Manetta, A, Berman, M L, McMeekin, S, Bloss, L P, DiSaia, P J

“…Since the establishment of extraovarian peritoneal serous papillary carcinoma (EPSPC) as a clinical entity in 1959, less than 250 cases have been described and…”
Get more information

A Retrospective Study of Tamoxifen and Endometrial Cancer in Breast Cancer Patients by ROBINSON, DALE C., BLOSS, JEFFREY D., SCHIANO, MICHAEL A.

“…Objective. To assess the relationship between low-dose tamoxifen, usage and endometrial cancer in breast cancer patients. Methods. In this case-control study,…”
Get full text

A Phase II Trial of Neoadjuvant Chemotherapy Prior to Radical Hysterectomy and/or Radiation Therapy in the Management of Advanced Carcinoma of the Uterine Cervix by Bloss, Jeffrey D., Lucci, Joseph A., DiSaia, Philip J., Manetta, Alberto, Schiano, Michael A., Ramsinghani, Nilam, Berman, Michael L.

“…Objective: This prospective trial was designed to access the efficacy and safety of neoadjuvant chemotherapy followed by radical hysterectomy and/or radiation…”
Get full text

Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology by Bloss, J D, Liao, S Y, Wilczynski, S P, Macri, C, Walker, J, Peake, M, Berman, M L

“…The association between the human papillomavirus (HPV) and malignant neoplasms of the uterine cervix is well established; however, its role in the pathogenesis…”
Get more information

Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix by Walker, J, Bloss, J D, Liao, S Y, Berman, M, Bergen, S, Wilczynski, S P

“…The clinical implications of specific human papillomavirus (HPV) types in invasive cervical carcinomas are only beginning to be appreciated. In this series of…”
Get more information

The use of electrosurgical techniques in the management of premalignant diseases of the vulva, vagina, and cervix: an excisional rather than an ablative approach by Bloss, J D

“…In recent years electrosurgical excision techniques have been advocated for the evaluation and treatment of premalignant diseases of the vulva, vagina, and…”
Get more information

Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient by Bloss, J D, Berman, M L, Bloss, L P, Buller, R E

“…Vaginal hysterectomy was performed on 31 patients with stage I endometrial cancer because of medical problems which placed them at high risk for morbidity and…”
Get more information

Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study by Anton-Culver, H, Bloss, J D, Bringman, D, Lee-Feldstein, A, DiSaia, P, Manetta, A

“…Our objective was to compare epidemiologic and clinical characteristics of adenocarcinoma with those of squamous cell carcinoma of the cervix, with respect to…”
Get more information

Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy by Bloss, J D, Berman, M L, Mukhererjee, J, Manetta, A, Emma, D, Ramsanghani, N S, DiSaia, P J

“…The management of bulky, stage IB cervical carcinoma remains controversial. The present study reports the outcome of 84 women treated by radical hysterectomy,…”
Get more information

Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survival by Buller, R E, Berman, M L, Bloss, J D, Manetta, A, DiSaia, P J

“…Findings at reassessment laparotomy and disease-free survival are reported for a group of patients with advanced-stage epithelial ovarian cancer who have had a…”
Get more information

CA 125 regression: a model for epithelial ovarian cancer response by Buller, R E, Berman, M L, Bloss, J D, Manetta, A, DiSaia, P J

“…The rate of decline of CA 125 in effectively treated epithelial ovarian cancer is described by the exponential regression curve CA 125 = EXP [i - s (days after…”
Get more information

Chemotherapy for advanced or recurrent carcinoma of the cervix by Bloss, J D

“…The management of early-stage cervical cancer involves primarily surgery and/or chemoradiotherapy. When the disease spreads beyond the cervix but remains…”
Get full text

Does intraperitoneal CA-125 reflect disease status? by Buller, R E, Manetta, A, Bloss, J D, DiSaia, P J, Berman, M L

“…The relationship of serum CA-125 to intraperitoneal (IP) CA-125 was studied in 45 patients with a variety of gynecologic diseases including ovarian carcinoma…”
Get more information

Radiation myelitis: a complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix by Bloss, J D, DiSaia, P J, Mannel, R S, Hyden, E C, Manetta, A, Walker, J L, Berman, M L

“…Radiation myelitis is a rare but serious complication of radiation therapy. The total dose of radiation to the spinal cord required to cause myelopathy is…”
Get more information

Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatment of advanced cervical cancer by Angiola, G, Bloss, J D, DiSaia, P J, Warner, A S, Manetta, A, Berman, M L

“…Hemolytic-uremic syndrome (HUS) is a rare but severe complication of neoplastic disease as well as some of its treatments. The pathophysiology of HUS is poorly…”
Get more information

Pulmonary edema as a delayed complication of ritodrine therapy. A case report by BLOSS, J. D, HANKINS, G. D. V, GILSTRAP, L. C. III, HAUTH, J. C

“…Pulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy. Standard therapy directed at volume…”
Get full text

The use of molecular probes to distinguish new primary tumors from recurrent tumors in gynecologic malignancies by Bloss, J D, Wilczynski, S P, Liao, S Y, Walker, J, Manetta, A, Berman, M L

“…This is the first report using DNA molecular probe technology to distinguish between recurrent tumor and a second primary malignancy in a patient. Tumor DNA…”
Get more information

The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy by Bloss, J D, Hankins, G D, Hauth, J C, Gilstrap, 3rd, L C

“…The effect of oxytocin infusion on the pharmacokinetics of standard intramuscular magnesium sulfate therapy was determined in 18 women with preeclampsia; the…”
Get more information

Breast Cancer Prevention by RODABAUGH, KERRY J, BLOSS, JEFFREY D

Get full text